We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology.
Acquire cell therapy manufacturing facility with clinical and commercial capabilitiesFurther ExacTcell platform for additional clinical trials based on successful completion of POCHighlight full...
Conversion of promissory notes into common stock removed $94.9 million in pro forma balance sheet liabilities.The converted common stock is included in the company’s total 165 million outstanding...
Successful completion of TVGN 489’s proof-of-concept clinical trial suggested the ability to target and eliminate a virus in high-risk population with multiple comorbidities.Tevogen Bio plans to...
WARREN, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc (‘Tevogen Bio’) (Nasdaq: TVGN), a clinical-stage biotech company, announces the appointment of Tapan V Shah as Head of...
WARREN, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings ('Tevogen Bio') (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf...
Tevogen Bio Holdings ('Tevogen Bio') (Nasdaq: TVGN), today announced TVGN 489, its investigational allogeneic SARS-CoV-2 specific Cytotoxic CD8+ T lymphocytes (CTLs) immunotherapy for treatment...
Tevogen Bio Holdings ('Tevogen Bio') (Nasdaq: TVGN), congratulates Victor Sordillo PE, CSP, MBA, on his recent appointment as Managing Director of Risk Advisory Services at Verita CSG, Inc., a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.23 | -19.1666666667 | 1.2 | 1.2 | 0.86 | 2405634 | 0.99943844 | CS |
4 | -2.47 | -71.8023255814 | 3.44 | 3.44 | 0.803 | 760032 | 1.24323023 | CS |
12 | -3.13 | -76.3414634146 | 4.1 | 21.09 | 0.803 | 648644 | 2.55623921 | CS |
26 | -3.13 | -76.3414634146 | 4.1 | 21.09 | 0.803 | 648644 | 2.55623921 | CS |
52 | -3.13 | -76.3414634146 | 4.1 | 21.09 | 0.803 | 648644 | 2.55623921 | CS |
156 | -3.13 | -76.3414634146 | 4.1 | 21.09 | 0.803 | 648644 | 2.55623921 | CS |
260 | -3.13 | -76.3414634146 | 4.1 | 21.09 | 0.803 | 648644 | 2.55623921 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions